Advinus and Celgene link up to discover new drugs for leishmaniasis
This article was originally published in Scrip
Executive Summary
Advinus Therapeutics of India and Celgene Global Health (CGH) have formed a discovery and development collaboration focused on therapies for visceral leishmaniasis.